Patents by Inventor Johnson T. Wong

Johnson T. Wong has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods for Treatment of HIV and Other Infections Using a T-Cell or Viral Activator and Anti-Retroviral Combination Therapy
    Publication number: 20140186296
    Abstract: Disclosed is a method for treating infection with a pathogen. The method involves administration of (1) a substance which induces active pathogen replication in a cell latently infected with HIV and (2) an anti-pathogen drug. Also disclosed are methods for expanding CD+ T cells from peripheral blood mononuclear cells isolated from human subjects in the presence of an antiretroviral drug and for treating HIV infection by infusing the expanded CD4+ cells into HIV-infected patients.
    Type: Application
    Filed: October 4, 2013
    Publication date: July 3, 2014
    Inventor: Johnson T. Wong
  • Methods for Treatment of HIV and Other Infections Using a T Cell or Viral Activator and Anti-Retroviral Combination Therapy
    Publication number: 20130064787
    Abstract: Disclosed is a method for treating infection with a pathogen. The method involves administration of: (1) a substance which induces active pathogen replication in a cell latently infected with HIV and (2) an anti-pathogen drug. Also disclosed are methods for expanding CD4+ T cells from peripheral blood mononuclear cells isolated from human subjects in the presence of an antiretroviral drug and for treating HIV infection by infusing the expanded CD4+ T cells into HIV-infected patients.
    Type: Application
    Filed: April 5, 2012
    Publication date: March 14, 2013
    Inventor: Johnson T. Wong
  • Methods for Treatment of HIV and Other Infections Using a T Cell or Viral Activator and Anti-Retroviral Combination Therapy
    Publication number: 20110229477
    Abstract: Disclosed is a method for treating infection with a pathogen. The method involves administration of (1) a substance which induces active pathogen replication in a cell latently infected with HIV and (2) an anti-pathogen drug. Also disclosed are methods for expanding CD4+ T cells from peripheral blood mononuclear cells isolated from human subjects in the presence of an antiretroviral drug and for treating HIV infection by infusing the expanded CD4+ cells into HIV-infected patients.
    Type: Application
    Filed: June 3, 2011
    Publication date: September 22, 2011
    Inventor: Johnson T. Wong
  • Methods for Treatment of HIV and Other Infections Using A T Cell or Viral Activator and Anti-Retroviral Combination Therapy
    Publication number: 20100124553
    Abstract: Disclosed is a method for treating infection with a pathogen. The method involves administration of: (1) a substance which induces active pathogen replication in a cell latently infected with HIV and (2) an anti-pathogen drug. Also disclosed are methods for expanding CD4+ T cells from peripheral blood mononuclear cells isolated from human subjects in the presence of an antiretroviral drug and for treating HIV infection by infusing the expanded CD4+ cells into HIV-infected patients.
    Type: Application
    Filed: June 17, 2009
    Publication date: May 20, 2010
    Inventor: Johnson T. Wong
  • Methods for treatment of HIV and other infections using a T cell or viral activator and anti-retroviral combination therapy
    Patent number: 6893813
    Abstract: Disclosed is a method for treating infection with a pathogen. The method involves administration of: (1) a substance which induces active pathogen replication in a cell latently infected with HIV and (2) an anti-pathogen drug. Also disclosed are methods for expanding CD4+ T cells from peripheral blood mononuclear cells isolated from human subjects in the presence of an antiretroviral drug and for treating HIV infection by infusing the expanded CD4+ cells into HIV-infected patients.
    Type: Grant
    Filed: December 23, 2002
    Date of Patent: May 17, 2005
    Inventor: Johnson T. Wong
  • Methods for treatment of HIV and other infections using a T cell or viral activator and anti-retroviral combination therapy
    Publication number: 20030108942
    Abstract: Disclosed is a method for treating infection with a pathogen. The method involves administration of: (1) a substance which induces active pathogen replication in a cell latently infected with HIV and (2) an anti-pathogen drug. Also disclosed are methods for expanding CD4+ T cells from peripheral blood mononuclear cells isolated from human subjects in the presence of an antiretroviral drug and for treating HIV infection by infusing the expanded CD4+ cells into HIV-infected patients.
    Type: Application
    Filed: December 23, 2002
    Publication date: June 12, 2003
    Inventor: Johnson T. Wong
  • Methods for treatment of HIV and other infections using A T cell or viral activator and anti-retroviral combination therapy
    Patent number: 6514758
    Abstract: Disclosed is a method for treating infection with a pathogen. The method involves administration of: (1) a substance which induces active pathogen replication in a cell latently infected with HIV and (2) an anti-pathogen drug. Also disclosed are methods for expanding CD4+ T cells from peripheral blood mononuclear cells isolated from human subjects in the presence of an antiretroviral drug and for treating HIV infection by infusing the expanded CD4+ cells into HIV-infected patients.
    Type: Grant
    Filed: March 18, 2002
    Date of Patent: February 4, 2003
    Inventor: Johnson T. Wong
  • Methods for treatment of HIV and other infections using A T cell or viral activator and anti-retroviral combination therapy
    Patent number: 6498006
    Abstract: Disclosed is a method for treating infection with a pathogen. The method involves administration of: (1) a substance which induces active pathogen replication in a cell latently infected with HIV and (2) an anti-pathogen drug. Also disclosed are methods for expanding CD4+ T cells from peripheral blood mononuclear cells isolated from human subjects in the presence of an antiretroviral drug and for treating HIV infection by infusing the expanded CD4+ cells into HIV-infected patients.
    Type: Grant
    Filed: November 24, 1998
    Date of Patent: December 24, 2002
    Assignee: Johnson T. Wong
    Inventor: Johnson T. Wong
  • Methods for treatment of HIV and other infections using A T cell or viral activator and anti-retroviral combination therapy
    Publication number: 20020094333
    Abstract: Disclosed is a method for treating infection with a pathogen. The method involves administration of: (1) a substance which induces active pathogen replication in a cell latently infected with HIV and (2) an anti-pathogen drug. Also disclosed are methods for expanding CD4+ T cells from peripheral blood mononuclear cells isolated from human subjects in the presence of an antiretroviral drug and for treating HIV infection by infusing the expanded CD4+ cells into HIV-infected patients.
    Type: Application
    Filed: March 18, 2002
    Publication date: July 18, 2002
    Inventor: Johnson T. Wong
  • METHODS FOR TREATMENT OF HIV AND OTHER INFECTIONS USING A T CELL OR VIRAL ACTIVATOR AND ANTI-RETROVIRAL COMBINATION THERAPY
    Publication number: 20010006776
    Abstract: Disclosed is a method for treating infection with a pathogen. The method involves administration of: (1) a substance which induces active pathogen replication in a cell latently infected with HIV and (2) an anti-pathogen drug. Also disclosed are methods for expanding CD4+ T cells from peripheral blood mononuclear cells isolated from human subjects in the presence of an antiretroviral drug and for treating HIV infection by infusing the expanded CD4+ cells into HIV-infected patients.
    Type: Application
    Filed: November 24, 1998
    Publication date: July 5, 2001
    Inventor: JOHNSON T. WONG
  • Bispecific antibodies for selective immune regulation and for selective immune cell binding
    Patent number: 5601819
    Abstract: Bispecific antibodies can be used to alter the ratio and proliferation of T cell subsets, to selectively target cells that coexpress two different surface antigens such as the activated T cell subsets, or to block the cytolytic function of specific T cell subsets.
    Type: Grant
    Filed: September 14, 1994
    Date of Patent: February 11, 1997
    Assignee: The General Hospital Corporation
    Inventors: Johnson T. Wong, Robert B. Colvin